Skip to main content
SpringerLink
Log in

Fortschritte bei der atopischen Dermatitis

New advances in atopic dermatitis

  • Übersichten
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Die atopische Dermatitis (AD) ist eine der häufigsten chronischen Hauterkrankungen und weist eine komplexe und vielschichtige Genese auf. In dieser Übersicht möchten wir einige ausgewählte Aspekte zur Pathophysiologie der AD zusammenfassen, die in den letzten Jahren viel Aufmerksamkeit gewonnen haben. Diese Aspekte haben die dermatologische Sichtweise dieser Erkrankung nachhaltig verändert und werden die Behandlung der AD in Zukunft verändern.

Abstract

Atopic Dermatitis (AD) is one of the most frequent chronic skin diseases. AD is characterized by a complex, heterogenous pathogenesis. In this review, we highlight some selected aspects of the pathophysiology of AD, which have gained much attention during recent years. These aspects profoundly changed our view of the pathogenesis of AD and will have impact on its management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Asher MI, Montefort S, Bjorksten B et al (2006) Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368(9537):733–743

    Article  PubMed  Google Scholar 

  2. Pawankar R, Canonica GW, Holgate ST, Lockey RF (o J) WAO White Book on Allergy 2011–2012

  3. Novak N, Simon D (2011) Atopic dermatitis – from new pathophysiologic insights to individualized therapy. Allergy 66(7):830–839

    Article  PubMed  Google Scholar 

  4. Barnes KC (2010) An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol 125(1):16–29

    Article  PubMed  CAS  Google Scholar 

  5. Bieber T (2008) Atopic dermatitis. N Engl J Med 358(14):1483–1494

    Article  PubMed  CAS  Google Scholar 

  6. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38(4):441–446

    Article  PubMed  CAS  Google Scholar 

  7. Irvine AD, McLean WH, Leung DY (2011) Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 365(14):1315–1327

    Article  PubMed  CAS  Google Scholar 

  8. Kezic S, Kemperman PM, Koster ES et al (2008) Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol 128(8):2117–2119

    Article  PubMed  CAS  Google Scholar 

  9. Miajlovic H, Fallon PG, Irvine AD, Foster TJ (2010) Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol 126(6):1184–1190

    Article  PubMed  CAS  Google Scholar 

  10. Brown SJ, Asai Y, Cordell HJ et al (2011) Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol 127(3):661–667

    Article  PubMed  CAS  Google Scholar 

  11. Bisgaard H, Simpson A, Palmer CN et al (2008) Gene-environment interaction in the onset of eczema in infancy: filaggrin loss-of-function mutations enhanced by neonatal cat exposure. PLoS Med 5(6):e131

    Article  PubMed  Google Scholar 

  12. Novak N, Baurecht H, Schafer T et al (2007) Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 128(6):1430–1435

    Article  PubMed  Google Scholar 

  13. Jongh CM de, Khrenova L, Verberk MM et al (2008) Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case-control study. Br J Dermatol 159(3):621–627

    Article  PubMed  Google Scholar 

  14. Gao PS, Rafaels NM, Mu D et al (2010) Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol 125(6):1403–1407

    Article  PubMed  CAS  Google Scholar 

  15. Betz RC, Pforr J, Flaquer A et al (2007) Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J Invest Dermatol 127(11):2539–2543

    Article  PubMed  CAS  Google Scholar 

  16. Basu K, Palmer CN, Lipworth BJ et al (2008) Filaggrin null mutations are associated with increased asthma exacerbations in children and young adults. Allergy 63(9):1211–1217

    Article  PubMed  CAS  Google Scholar 

  17. Fallon PG, Sasaki T, Sandilands A et al (2009) A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 41(5):602–608

    Article  PubMed  CAS  Google Scholar 

  18. Howell MD, Kim BE, Gao P et al (2007) Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 120(1):150–155

    Article  PubMed  CAS  Google Scholar 

  19. Hvid M, Vestergaard C, Kemp K et al (2011) IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 131(1):150–157

    Article  PubMed  CAS  Google Scholar 

  20. Grewe M, Bruijnzeel-Koomen CA, Schopf E et al (1998) A role for th1 and th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19(8):359–361

    Article  PubMed  CAS  Google Scholar 

  21. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485–517

    Article  PubMed  CAS  Google Scholar 

  22. Milner JD, Brenchley JM, Laurence A et al (2008) Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452(7188):773–776

    Article  PubMed  CAS  Google Scholar 

  23. Eyerich K, Pennino D, Scarponi C et al (2008) IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. J Allergy Clin Immunol 123(1):59–66

    Article  PubMed  Google Scholar 

  24. Heratizadeh A, Mittermann I, Balaji H et al (2011) The role of T-cell reactivity towards the autoantigen alpha-NAC in atopic dermatitis. Br J Dermatol 164(2):316–324

    Article  PubMed  CAS  Google Scholar 

  25. Oyoshi MK, Murphy GF, Geha RS (2009) Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J Allergy Clin Immunol 124(3):485–493, 493

    Article  PubMed  CAS  Google Scholar 

  26. He R, Oyoshi MK, Jin H, Geha RS (2007) Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc Natl Acad Sci U S A 104(40):15817–15822

    Article  PubMed  CAS  Google Scholar 

  27. Costanzo A, Chimenti MS, Botti E et al (2010) IL-21 in the pathogenesis and treatment of skin diseases. J Dermatol Sci 60(2):61–66

    Article  PubMed  CAS  Google Scholar 

  28. Jin H, Oyoshi MK, Le Y et al (2009) IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice. J Clin Invest 119(1):47–60

    PubMed  CAS  Google Scholar 

  29. Nograles KE, Zaba LC, Shemer A et al (2009) IL-22-producing „T22“ T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 123(6):1244–1252

    Article  PubMed  CAS  Google Scholar 

  30. Nograles KE, Zaba LC, Guttman-Yassky E et al (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 159(5):1092–1102

    PubMed  CAS  Google Scholar 

  31. Boniface K, Bernard FX, Garcia M et al (2005) IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174(6):3695–3702

    PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seinen Koautor an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie und Allergologie, Rheinische Friedrich-Wilhelms-Universität, Sigmund-Freud-Str. 25, 53105, Bonn, Deutschland

    N. Novak &  T. Bieber MDRA

Authors
  1. N. Novak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Bieber MDRA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Bieber MDRA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Novak, N., Bieber, T. Fortschritte bei der atopischen Dermatitis. Hautarzt 63 (Suppl 1), 67–70 (2012). https://doi.org/10.1007/s00105-011-2298-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-011-2298-3

Schlüsselwörter

Keywords

Search

Navigation